Basilea Pharmaceutica AG (BSLN.SW)

CHF 41.65

(0.24%)

Annual Balance Sheets

(In CHF)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 173.28 Million 220.84 Million 247.26 Million 229.79 Million 221.46 Million 281.75 Million
Total Current Assets 152.14 Million 175.36 Million 241.06 Million 223.52 Million 184.86 Million 274.73 Million
Cash And Short Term Investments 64.32 Million 86.56 Million 149.95 Million 167.27 Million 131.04 Million 223.03 Million
Cash and Cash Equivalents 12.48 Million 36.56 Million 54.95 Million 55.6 Million 54.52 Million 173.03 Million
Short Term Investments 51.83 Million 50 Million 95 Million 111.67 Million 76.52 Million 50 Million
Net Receivables 58.14 Million 61.7 Million 64.44 Million 32.39 Million 28.29 Million 3.75 Million
Inventory 26.41 Million 24.24 Million 22.78 Million 21.19 Million 18.56 Million 14.41 Million
Other Current Assets 3.26 Million 2.84 Million 3.88 Million 2.66 Million 6.95 Million 33.53 Million
Total Non-Current Assets 21.14 Million 45.48 Million 6.2 Million 6.26 Million 36.6 Million 6.79 Million
Net PPE 20.55 Million 21.57 Million 2.92 Million 5.27 Million 5.16 Million 6.42 Million
Good Will And Intangible Assets 548 Thousand 578 Thousand 632 Thousand 672 Thousand 372 Thousand 372 Thousand
Good Will - - - - - -
Intangible Assets 548 Thousand 578 Thousand 632 Thousand 672 Thousand 372 Thousand 372 Thousand
Long-Term Investments - 23.26 Million 2.39 Million - 30 Million -
Tax Assets - - -1.00 - - -
Other Non Current Assets 43.99 Thousand 69 Thousand 256 Thousand 319 Thousand 1.07 Million -6.79 Million
Other Assets 1.00 - 1.00 - - 217 Thousand
Total Liabilities 183.29 Million 241.56 Million 305.87 Million 331.84 Million 314.42 Million 348.43 Million
Total Current Liabilities 47.59 Million 74.85 Million 174.4 Million 50.16 Million 75.49 Million 66.68 Million
Account Payables 5.84 Million 191 Thousand 10.61 Million 13.15 Million 6.76 Million 6.39 Million
Tax Payables - 1 Million 1.5 Million 1.6 Million 1.1 Million 8.6 Million
Short Term Debt 17.51 Million 39.45 Million 124.4 Million 1.75 Million 1.00 -25.02 Million
Deferred Revenue 1.23 Million 1.23 Million 1.23 Million 2.55 Million 32.87 Million 25.02 Million
Other Current Liabilities 22.99 Million 33.97 Million 38.15 Million 32.7 Million 35.85 Million 60.28 Million
Total Non Current Liabilities 135.7 Million 166.71 Million 131.46 Million 281.67 Million 238.93 Million 196.98 Million
Long-Term Debt 95.45 Million 131.36 Million 94.54 Million 239.66 Million 197.74 Million 196.98 Million
Deferred Revenue Non Current 9.46 Million 10.69 Million 11.92 Million 13.15 Million 16.47 Million 69.94 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 15.14 Million 8.33 Million 24.98 Million 27.95 Million 24.72 Million -196.98 Million
Other Liabilities - - - - - 84.77 Million
Total Equity -10 Million -20.71 Million -58.6 Million -102.04 Million -92.96 Million -66.68 Million
Stock Holders Equity -10 Million -20.71 Million -58.6 Million -102.04 Million -92.96 Million -66.68 Million
Common Stock 13.1 Million 13.09 Million 12.99 Million 11.92 Million 11.88 Million 11.87 Million
Retained Earnings -1 Billion -1.01 Billion -1.02 Billion -1.01 Billion -1 Billion -979.24 Million
Accumulated other comprehensive income -10.21 Million -3.78 Million -21.61 Million -27.25 Million -24.55 Million -16.3 Million
Common Stock Equity -10 Million -20.71 Million -58.6 Million -102.04 Million -92.96 Million -66.68 Million
Capital Lease Obligation 15.63 Million 16.32 Million 10 Thousand 896 Thousand 900 Thousand -
Total Investments 51.83 Million 73.26 Million 97.39 Million 111.67 Million 106.52 Million 50 Million
Total Debt 128.6 Million 187.13 Million 218.95 Million 242.31 Million 197.74 Million 196.98 Million
Net Debt 116.11 Million 150.57 Million 164 Million 186.7 Million 143.22 Million 23.94 Million

Balance Sheet Charts